118 related articles for article (PubMed ID: 8402746)
1. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
Sau F; Seguro C; Lai C; Onnis E; Orani E; Soro A; Leo MR; Cherchi A
Cardiologia; 1993 Jun; 38(6):369-76. PubMed ID: 8402746
[TBL] [Abstract][Full Text] [Related]
2. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Sau F; Seguro C; Pargentino E
Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
[TBL] [Abstract][Full Text] [Related]
3. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
[TBL] [Abstract][Full Text] [Related]
4. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
[TBL] [Abstract][Full Text] [Related]
5. [Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Sau F; Seguro C; Pili G; Basciu M; Siddi PP; Tamponi R; Cherchi A
Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370
[TBL] [Abstract][Full Text] [Related]
6. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
8. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
12. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
Sabatini D; Fazio S; Cittadini A; Biondi B; Lucariello A; Picano T; Saccà L
Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
14. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
da Costa W; Riera AR; Costa Fde A; Bombig MT; de Paola AA; Carvalho AC; Fonseca FH; Luna Filho B; Póvoa R
J Electrocardiol; 2008; 41(6):724-9. PubMed ID: 18954613
[TBL] [Abstract][Full Text] [Related]
15. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
[TBL] [Abstract][Full Text] [Related]
16. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
[TBL] [Abstract][Full Text] [Related]
17. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
18. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.
Sheiban I; Arcaro G; Covi G; Accardi R; Zenorini C; Lechi A
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S187-91. PubMed ID: 2455130
[TBL] [Abstract][Full Text] [Related]
19. Plasma catecholamine and cardiovascular responses to nifedipine in hypertensives WHO-stage II.
Lehmann M; Dürr H; Arratibel-Imaz I; Balle C; Keller E; Merkelbach H; Keul J
Arzneimittelforschung; 1989 Dec; 39(12):1593-6. PubMed ID: 2624611
[TBL] [Abstract][Full Text] [Related]
20. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]